Peripheral Neuropathy and Listing 11.14: SSDI Rules

Peripheral neuropathy can qualify for Social Security Disability Insurance (SSDI) under Blue Book Listing 11.14 when the nerve damage causes either disorganization of motor function in two extremities or a specific combination of marked physical and mental limitations. The Social Security Administration (SSA) publishes the listing in the neurological body system, 20 CFR Part 404, Subpart P, Appendix 1, and it offers exactly two routes to approval.

Neuropathy means disease of the peripheral nerves, the nerves outside the brain and spinal cord. Depending on which fibers are damaged it produces numbness, tingling, burning pain, weakness, loss of balance, and loss of fine touch, most often in the feet and hands. Common causes include diabetes, kidney disease, chemotherapy, alcohol use disorder, vitamin deficiencies, and autoimmune disease. Whatever the cause, SSA evaluates the resulting limitations under the same two paragraphs.

Establishing the Impairment Before the Listing Applies

A listing cannot be met until the disorder itself is established. Section 11.00B of the neurological listings requires medical evidence that includes medical history, examination findings, relevant laboratory tests, and the results of imaging. Acceptable imaging named in 11.00B includes x-ray, computed tomography (CT), magnetic resonance imaging (MRI), and electroencephalography (EEG), provided the technique matches prevailing medical practice for the disorder being evaluated.

Under 20 CFR 404.1521, the impairment must be shown by objective medical evidence from an acceptable medical source under 20 CFR 404.1513, typically a licensed physician or neurologist. Statements about numbness or burning, no matter how sincere, cannot substitute for documented signs such as reduced muscle strength measured on a standard grading scale, decreased sensation to pinprick or vibration, absent ankle reflexes, or abnormal nerve conduction studies.

SSA also weighs nonmedical evidence under 11.00B, including statements from the claimant and others about daily activities, restrictions, and efforts to work, when assessing how the documented signs translate into functioning.

Listing 11.14A: Disorganization of Motor Function in Two Extremities

Paragraph A is the motor route. It requires disorganization of motor function in two extremities, as defined in section 11.00D1, resulting in an extreme limitation in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities.

Section 11.00D1 defines the reach of the two-extremity rule. Two extremities means both lower extremities, both upper extremities, or one upper extremity and one lower extremity. Neuropathy affecting both feet, or one arm and one leg, therefore counts, provided the functional loss is severe enough.

Extreme limitation is defined strictly in section 11.00D2. It means the inability to stand up from a seated position without the assistance of another person or an assistive device such as a walker, two crutches, or two canes, the inability to maintain an upright position while standing or walking without the same kind of help, or the inability to use the upper extremities to independently initiate, sustain, and complete work-related activities.

For the arms, that standard covers the loss of the ability to pinch, manipulate, and use the fingers, to grip, grasp, hold, turn, and reach, and to lift, carry, push, and pull. A claimant who can still rise from a chair and steady herself on a wall, or who retains use of both hands for routine handling, will usually fall short of paragraph A even with a firm neuropathy diagnosis.

Listing 11.14B: Marked Physical and Mental Limitations

Paragraph B is the combined route, and it requires two findings at once. First, a marked limitation in physical functioning under section 11.00G3a. Second, a marked limitation in at least one of the four areas of mental functioning.

Marked limitation is defined in section 11.00G2. It means seriously limited, which would be the fourth point on a five-point scale running from no limitation through mild, moderate, marked, and extreme. A person need not be confined to bed or totally prevented from an activity, but the limitation must seriously interfere with functioning on a sustained basis.

Physical functioning under 11.00G3a covers the ability to independently initiate, sustain, and complete work-related physical activities, such as standing up from a seated position, balancing while standing or walking, and using both upper extremities for fine and gross movements. Symptoms such as pain or fatigue, when documented in the record and caused by the neurological disorder or its treatment, can drive this finding, as can limits that combine across several activities.

The four areas of mental functioning, described with examples in section 11.00G3b, are:

• Understanding, remembering, or applying information, meaning learning and using instructions and procedures.
• Interacting with others, meaning cooperating with supervisors, coworkers, and the public.
• Concentrating, persisting, or maintaining pace, meaning staying on task at a consistent rate.
• Adapting or managing oneself, meaning regulating emotions and behavior and maintaining personal care in a work setting.

Under 11.00G3a, if a mental limitation alone reaches the extreme level, or two areas are markedly limited, but physical functioning is not at least markedly limited, SSA turns instead to the mental disorders body system in 12.00. Neuropathy claims succeed under paragraph B most often when physical limits from weakness or pain combine with documented cognitive slowing, medication effects, or a depressive disorder secondary to chronic illness.

Treatment, Fatigue, and Adherence

Listing 11.14 does not contain a despite-adherence-to-treatment requirement. Section 11.00C imposes that extra requirement only for Listing 11.02 (epilepsy), Listing 11.06 (Parkinsonian syndrome), and Listing 11.12 (myasthenia gravis). For neuropathy, SSA instead evaluates the effects of treatment in the ordinary way under 11.00G4, considering medication side effects, dosing burdens, and how function varies with response to therapy.

Fatigue gets its own instruction in section 11.00T. SSA considers the intensity, persistence, and effects of physical and mental fatigue when it evaluates motor function under 11.00D and combined physical and mental functioning under 11.00G. For neuropathy claimants, the heavy, rapidly exhausting legs that follow brief walking belong in the record, because that pattern of fatigue can be decisive.

When Neuropathy Does Not Meet the Listing

Section 11.00U controls the fallback analysis. If no listing is met, SSA must consider whether the impairment medically equals a listing under 20 CFR 404.1526, comparing the combined findings against the closest criteria. If none is met or equaled, the sequential evaluation under 20 CFR 404.1520 proceeds to residual functional capacity (RFC) under 20 CFR 404.1545.

Neuropathy-driven RFC limits frequently include reduced standing and walking tolerance from loss of position sense, a need to avoid ladders and unprotected heights because of imbalance, loss of fine finger movements that undercuts sedentary handling and fingering, and off-task time from burning pain. An inability to sustain the standing and walking that even sedentary work requires under 20 CFR 404.1567(a), roughly 2 hours of an 8-hour day, can erode the unskilled sedentary occupational base described in Social Security Ruling SSR 96-9p.

At step five, the medical-vocational guidelines in 20 CFR Part 404, Subpart P, Appendix 2 direct many findings of disabled for claimants age 50 and older who are limited to sedentary or light exertion and lack transferable skills. Claimants under 50 generally must show that nonexertional limits, such as pain-driven off-task time or the inability to use both hands for handling, remove the remaining jobs.

NonMedical SSDI Requirements in 2026

SSDI also requires insured status and earnings below the substantial gainful activity (SGA) level. Under 20 CFR 404.130, most workers need at least 20 credits earned in the 10 years ending with disability onset. In 2026, one work credit is credited for each $1,860 in covered earnings, up to four credits per year.

Under 20 CFR 404.1574, the 2026 monthly SGA limit is $1,670 for non-blind claimants and $2,780 for statutorily blind claimants. Earnings above the limit generally produce a step-one denial before the neuropathy evidence is ever weighed.

Frequently Asked Questions

What does Listing 11.14 require for peripheral neuropathy? Listing 11.14 is satisfied by either paragraph A, disorganization of motor function in two extremities resulting in extreme limitation in standing up, balancing, or using the arms, or paragraph B, a marked limitation in physical functioning plus a marked limitation in one of the four areas of mental functioning.

Do both legs have to be affected to meet Listing 11.14A? No. Under section 11.00D1, two extremities means both lower extremities, both upper extremities, or one upper and one lower extremity. Many conditions qualify, but the resulting limitation must reach the extreme level defined in 11.00D2.

Does neuropathy from diabetes qualify for SSDI? Yes, when it is severe. SSA evaluates diabetic nerve damage under Listing 11.14 the same as any other peripheral neuropathy, and the underlying diabetes does not change the two-paragraph structure of the listing.

This article provides general information about Social Security Disability Insurance eligibility, not legal advice. Program rules and medical criteria change over time, and all figures cited here reflect the standards in effect in 2026. Consult a qualified representative or contact the Social Security Administration directly for guidance on your specific claim.